Climb Bio, Inc. (CLYM) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts CLYM Hot Sheet
Join SI Premium – FREE
Climb Bio, Inc. (NASDAQ: CLYM) reported Q2 EPS of ($0.18), $0.03 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan upgrades Kraft Heinz credit to Overweight on deleveraging outlook
- Sonoma Pharmaceuticals (SNOA) Tops Q1 EPS by 21c
- Alpha Pro Tech Ltd. (APT) Reports Q2 EPS of $0.16
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
